Synthesis and evaluation of novel phosphasugar anticancer agents

9Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Starting materials of phosphasugars, 1-phenyl-2-phospholene 1-oxides, were prepared from dienes and phenylphosphonous dichloride (dichlorophenylphosphine). Several substituted novel phosphasugars (3- or 4-halo-substituted)-1-phenyl-2-phospholene 1-oxides as well as 1-phenyl-2-phospholane 1-oxides were prepared from 2-phospholenes. The synthesized compounds were evaluated for their antitumor activities against the leukemia cell lines (U937 and K562) by in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 2,3,4-Tribromo-3-methyl-1-phenylphospholane 1-oxide showed superior antitumor activity against U937 and K562 cell lines in a comparative evaluation with Glivec. The analysis by flow cytometry implied that 2,3-dibromo-3-methyl-1-phenylphospholane 1-oxide induced apoptosis to leukemia cell lines. © 2011 IUPAC.

Cite

CITATION STYLE

APA

Yamaoka, M., Yamashita, M., Yamada, M., Fujie, M., Kiyofuji, K., Ozaki, N., … Ohnishi, K. (2012). Synthesis and evaluation of novel phosphasugar anticancer agents. Pure and Applied Chemistry, 84(1), 37–48. https://doi.org/10.1351/PAC-CON-11-10-09

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free